- 12. Until  the  Commission  has  designated,  pursuant  to  Article  27(2),  issuing  entities,  GS1,  HIBCC  and  ICCBBA  shall be considered to be designated issuing entities.
## Article 121
## Evaluation
- By  27  May  2027,  the  Commission  shall  assess  the  application  of  this  Regulation  and  produce  an  evaluation  report  on the  progress  towards  achievement  of  the  objectives  contained  herein  including  an  assessment  of  the  resources  required to  implement  this  Regulation.  Special  attention  shall  be  given  to  the  traceability  of  medical  devices  through  the  storage, pursuant to Article 27, of the UDI by economic operators, health institutions and health professionals.
## Article 122
## Repeal
Without  prejudice  to  Articles  120(3)  and  (4)  of  this  Regulation,  and  without  prejudice  to  the  obligations  of  the Member  States  and  manufacturers  as  regards  vigilance  and  to  the  obligations  of  manufacturers  as  regards  the  making available  of  documentation,  under  Directives  90/385/EEC  and  93/42/EEC,  those  Directives  are  repealed  with  effect  from 26 May 2020, with the exception of:
- -  Articles  8  and  10,  points  (b)  and  (c)  of  Article  10b(1),  Article  10b(2)  and  Article  10b(3)  of  Directive  90/385/EEC, and the obligations relating to vigilance and clinical investigations provided for  in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation;
- -  Article  10a  and  point  (a)  of  Article  10b(1)  of  Directive  90/385/EEC,  and  the  obligations  relating  to  registration  of devices  and  economic  operators,  and  to  certificate  notifications,  provided  for  in  the  corresponding  Annexes,  which are  repealed  with  effect  from  18  months  after  the  later  of  the  dates  referred  to  in  point  (d)  of  Article  123(3)  of  this Regulation;
- -  Article  10,  points  (c)  and  (d)  of  Article  14a(1),  Article  14a(2),  Article  14a(3)  and  Article  15  of  Directive  93/42/EEC, and the obligations relating to vigilance and clinical investigations provided for  in the corresponding Annexes, which are repealed with effect from the later of the dates referred to in point (d) of Article 123(3) of this Regulation; and - -  Article  14(1)  and  (2)  and  points  (a)  and  (b)  of  Article  14a(1)  of  Directive  93/42/EEC,  and  the  obligations  relating  to registration  of  devices  and  economic  operators,  and  to  certificate  notifications,  provided  for  in  the  corresponding Annexes,  which  are  repealed  with  effect  from  18  months  after  the  later  of  the  dates  referred  to  in  point  (d)  of Article 123(3) of this Regulation.
As  regards  the  devices  referred  to  in  Article  120  (3)  and  (4)  of  this  Regulation,  the  Directives  referred  to  in  the first  paragraph  shall  continue  to  apply  until  27  May  2025  to  the  extent  necessary  for  the  application  of  those paragraphs.
Notwithstanding  the  first  paragraph,  Regulations  (EU)  No  207/2012  and  (EU)  No  722/2012  shall  remain  in  force  and continue  to  apply  unless  and  until  repealed  by  implementing  acts  adopted  by  the  Commission  pursuant  to  this Regulation.
References to the repealed Directives shall be understood as references to this Regulation and shall be read in accordance with the correlation table laid down in Annex XVII to this Regulation.
## Article 123
## Entry into force and date of application
- 1. This Regulation shall enter  into force on the twentieth day following that of its publication in the Official  Journal  of the European Union .
